[Efficacy and tolerability of paroxetine in the treatment of the depressive phase of bipolar disorders]

Minerva Psichiatr. 1996 Jun;37(2):91-7.
[Article in Italian]

Abstract

Eighty patients aged between 20-65 years and suffering from bipolar disease according to DSM IV criteria, were treated with paroxetine for os at the single dosage of 20-40 mg/die. At regular intervals psychometric reagents were administered for the evaluation and the variations in the bipolar disease. Tolerability was excellent and side-effects mild, with a tendency to regress after the second week of therapy. The clinical assessment and the psychometric findings both suggest that paroxetina has a useful action on the bipolar disease.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / therapeutic use*
  • Bipolar Disorder / diagnosis
  • Bipolar Disorder / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Paroxetine / administration & dosage
  • Paroxetine / therapeutic use*
  • Psychiatric Status Rating Scales

Substances

  • Antidepressive Agents
  • Paroxetine